Comparing Aciclovir Dosage Options
Standard Aciclovir Strengths Available
Aciclovir tablets come in three main strengths: 200mg, 400mg, and 400mg. The 400mg strength represents the most commonly prescribed option for cold sore treatment, offering an effective balance between therapeutic benefit and dosing convenience. This strength typically requires taking one tablet five times daily during an outbreak, which many patients find manageable whilst maintaining consistent antiviral levels.
Aciclovir 200mg: Lower Strength Option
The 200mg strength may be considered for patients who experience mild cold sore outbreaks or those using aciclovir for suppressive therapy. This lower dose often requires more frequent administration - typically one tablet five times daily for acute treatment. Whilst this strength can be effective, many healthcare providers prefer the 400mg option due to improved patient compliance and comparable efficacy profiles.
Aciclovir 400mg: The Standard Choice
Aciclovir 400mg tablets represent the gold standard for cold sore treatment in the UK. This strength offers optimal antiviral activity whilst maintaining a practical dosing schedule. Research suggests that 400mg taken five times daily for five days can significantly reduce outbreak duration and symptom severity. EverydayMeds stocks aciclovir 400mg tablets, which many prescribers favour due to proven clinical effectiveness and patient convenience.
Higher Strength Considerations
The 400mg strength is less commonly prescribed for cold sores, being more often reserved for conditions like shingles or chickenpox. However, some treatment protocols may utilise this higher strength for severe outbreaks or immunocompromised patients. The dosing frequency for 400mg tablets typically differs from lower strengths, often requiring fewer daily doses but over extended periods.
Factors Affecting Strength Selection
Healthcare providers consider several factors when selecting aciclovir strength, including outbreak frequency, symptom severity, patient medical history, and potential drug interactions. Patients with frequent recurrences might benefit from suppressive therapy using lower daily doses, whilst those with severe outbreaks may require higher strengths for acute treatment. Individual response to treatment also influences strength selection, as some patients may respond better to specific dosing regimens.
Treatment Timing and Effectiveness
Regardless of strength chosen, aciclovir works most effectively when started early in the cold sore cycle, ideally during the initial tingling phase. The antiviral mechanism involves interfering with viral DNA replication, which is most active during early outbreak stages. Starting treatment within 24 hours of symptom onset typically provides the best outcomes, regardless of whether using 200mg, 400mg, or 400mg tablets.
